Tonix Pharma (TNXP) – Management Comments
-
Tonix Pharma (TNXP) says plans advancing to construct commercial-scale manufacturing facility to develop and manufacture vaccines in Bitterroot Valley
-
Tonix Pharma (TNXP) Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at ASCP
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TNXP Stock Lookup